|
Market Closed -
OTC Markets
20:56:40 25/03/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +48.94% |
|
+12.00% | +131.40% |
| Market Cap | 1.55M 1.35M 1.27M 1.15M 2.16M 148M 2.17M 15.2M 5.87M 75.42M 5.81M 5.68M 243M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 927K 875K 795K 1.49M 102M 1.5M 10.46M 4.04M 51.91M 4M 3.91M 167M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +48.94% | ||
| 1 week | +12.00% | ||
| Current month | +12.00% | ||
| 1 month | +12.00% | ||
| 3 months | +39.30% | ||
| 6 months | +48.94% | ||
| Current year | +131.40% |
| 1 week | 0.26 | 0.28 | |
| 1 month | 0.25 | 0.28 | |
| Current year | 0.12 | 0.28 | |
| 1 year | 0.1 | 0.28 | |
| 3 years | 0 | 0.34 | |
| 5 years | 0 | 0.64 | |
| 10 years | 0 | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 09/01/2018 |
James Anderson
CEO | Chief Executive Officer | 56 | 22/09/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 01/01/2006 |
James Anderson
BRD | Director/Board Member | 56 | 01/12/2006 |
Regina Anderson
CHM | Chairman | 79 | 01/09/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/31/24 A | Other | Director | 12,848 | 0.1585% | ||
| 7/31/24 A | Other | Director | 7,200 | 0.0888% | ||
| 7/31/24 A | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +48.94% | +12.00% | +174.51% | +1.73% | 2.13M | ||
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | ||
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | ||
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | ||
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | ||
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | ||
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | ||
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | ||
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | ||
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | ||
| Average | +4.93% | +2.93% | +40.98% | +40.95% | 360.17B | |
| Weighted average by Cap. | -0.04% | +3.09% | +35.15% | +61.76% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.08M 3.85M 3.5M 6.56M 449M 6.59M 46.06M 17.79M 229M 17.6M 17.21M 735M | 4.98M 4.34M 4.1M 3.72M 6.97M 478M 7M 48.99M 18.92M 243M 18.72M 18.31M 782M |
| Net income | -50.24K -43.74K -41.29K -37.52K -70.28K -4.82M -70.6K -494K -191K -2.45M -189K -185K -7.88M | -341K -297K -280K -255K -477K -32.71M -479K -3.35M -1.3M -16.63M -1.28M -1.25M -53.51M |
| Net Debt | -427K -372K -351K -319K -598K -40.99M -601K -4.2M -1.62M -20.84M -1.61M -1.57M -67.05M | -482K -420K -396K -360K -674K -46.22M -677K -4.74M -1.83M -23.51M -1.81M -1.77M -75.62M |
Employees
20
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
















